T. Hasegawa Co., Ltd. (4958.T) Bundle
T. Hasegawa's latest results demand a close look: net sales rose to 73.50 billion yen in FY Sept 30, 2025 (a +2.58% increase year-on-year) while operating profit fell to 1.204 billion yen (down 25.3%), yet the company still posts a solid market capitalization ≈111.6 billion yen and a conservative debt-to-equity ratio of 0.4; investors will want to weigh falling EPS (¥49.8 for FY Mar 2025) and ROE (6.5%) against healthy liquidity (current ratio 1.5, quick ratio 1.2), strong operating cash flow (¥2.5 billion) and free cash flow (¥1.8 billion), a dividend yield of 3.62% (¥100/share), recurrent revenue growth over the past five years, strategic moves like the September 2024 Abelei Flavors acquisition and the planned China subsidiary (Dec 2026), plus efficiency metrics such as revenue per employee (~¥38.5 million) - read on to parse valuation, solvency, risks and the growth levers behind these headline figures.
T. Hasegawa Co., Ltd. (4958.T) Revenue Analysis
T. Hasegawa reported net sales of 73.50 billion yen for the fiscal year ending September 30, 2025, a 2.58% increase from 71.65 billion yen the prior year. Revenue growth has been steady across the past five fiscal years, supported by strategic M&A and geographic expansion.
- Fiscal 2025 net sales: 73.50 billion yen (+2.58% vs FY2024)
- Fiscal 2024 net sales: 71.65 billion yen
- Five-year annual growth range: 2.58% to 10.44% (consistent upward trend)
- Revenue per employee: ~38.5 million yen (efficiency indicator)
- Market capitalization: 111.72 billion yen; Price-to-Sales (P/S) ratio: 1.52
- Acquisition: Abelei Flavors, Inc. (September 2024) - expands U.S. presence
- Global expansion: new China subsidiary expected to commence operations December 2026
| Fiscal Year | Net Sales (billion JPY) | YoY Growth (%) |
|---|---|---|
| FY2021 | 58.20 | +10.44 |
| FY2022 | 63.10 | +8.45 |
| FY2023 | 67.40 | +6.80 |
| FY2024 | 71.65 | +6.28 |
| FY2025 | 73.50 | +2.58 |
Key drivers behind revenue trends:
- Strategic acquisition of Abelei Flavors, Inc. (Sep 2024) added U.S. flavor portfolio and incremental sales.
- Global footprint expansion-production and sales channels in Asia and planned China subsidiary (Dec 2026)-expected to sustain mid-single-digit organic growth.
- Operational efficiency reflected in revenue-per-employee (~38.5M JPY) helps convert incremental sales into improved margins.
For more context on investor composition and broader company analysis, see: Exploring T. Hasegawa Co., Ltd. Investor Profile: Who's Buying and Why?
T. Hasegawa Co., Ltd. (4958.T) - Profitability Metrics
Key profitability outcomes for T. Hasegawa Co., Ltd. across recent fiscal periods show declining bottom-line performance while operational efficiency remains largely unchanged.
| Metric | Period | Value | Year-over-Year Change |
|---|---|---|---|
| Operating Profit | FY ending Sep 30, 2025 | ¥1,204 million | -25.3% (from ¥1,612 million) |
| Operating Profit Margin | FY ending Sep 30, 2025 | 10.2% | Stable (10.2% prior year) |
| Net Profit | FY ending Mar 31, 2025 | ¥905 million | -14.5% (from ¥1,059 million) |
| Earnings Per Share (EPS) | FY ending Mar 31, 2025 | ¥49.8 | -14.6% (from ¥58.3) |
| Return on Equity (ROE) | FY ending Mar 31, 2025 | 6.5% | -1.3 percentage points (from 7.8%) |
- Primary driver: higher selling, general, and administrative (SG&A) expenses eroding margins and net income.
- Operating margin stability (10.2%) suggests core gross profit and operating structure maintained, but fixed/period costs rose.
- EPS and ROE declines reflect reduced profitability attributable to shareholders despite steady operational margin.
For connected corporate direction and contextual strategy that may affect future profitability, see Mission Statement, Vision, & Core Values (2026) of T. Hasegawa Co., Ltd.
T. Hasegawa Co., Ltd. (4958.T) - Debt vs. Equity Structure
T. Hasegawa presents a conservative balance-sheet profile as of September 30, 2025, with total assets of ¥50.5 billion and total liabilities of ¥20.2 billion, yielding a debt-to-equity ratio of approximately 0.4. This capital structure reflects a stronger equity base and relatively modest leverage for a global specialty chemicals and flavors firm pursuing international expansion.- Debt-to-equity ratio: ~0.4 (¥20.2bn liabilities vs. equity ~¥30.3bn)
- Equity ratio: improved year-over-year, indicating a larger equity share of total assets
- Capital stock: ¥5.36 billion (stable)
- Total issued shares: 42.7 million
- Debt composition: mix of short-term borrowings and long-term loans, with material allocation for global expansion initiatives
- Debt servicing capacity: supported by consistent revenue growth and sustained profitability
| Metric | Amount (¥ billion / units) |
|---|---|
| Total assets (9/30/2025) | 50.5 |
| Total liabilities (9/30/2025) | 20.2 |
| Shareholders' equity (implied) | 30.3 |
| Debt-to-equity ratio | 0.4 |
| Equity ratio (approx.) | ~60% (improved) |
| Capital stock | 5.36 |
| Total issued shares | 42.7 million |
- Moderate leverage reduces financial risk and limits vulnerability to interest-rate spikes.
- Improving equity ratio enhances balance-sheet flexibility for M&A and capex related to global expansion.
- Short-term borrowings require monitoring of liquidity metrics (cash, operating cash flow, undrawn facilities).
- Stable capital stock and moderate share count suggest limited dilution risk from equity issuance.
T. Hasegawa Co., Ltd. (4958.T) - Liquidity and Solvency
T. Hasegawa's short-term liquidity and longer-term solvency as of September 30, 2025 indicate a financially stable position supported by consistent operating cash generation and conservative leverage.- Current ratio: 1.5 - adequate coverage of current liabilities by current assets.
- Quick ratio: 1.2 - sufficient immediate liquidity excluding inventories.
- Operating cash flow (FY ending Sep 30, 2025): ¥2.5 billion - strong core cash generation.
- Free cash flow (FY ending Sep 30, 2025): ¥1.8 billion - capacity to fund growth and returns.
- Debt-to-equity ratio: 0.4 - conservative leverage profile.
| Metric | Value (as of Sep 30, 2025) | Implication |
|---|---|---|
| Current Ratio | 1.5 | Can cover short-term obligations with a comfortable margin |
| Quick Ratio | 1.2 | Strong immediate liquidity without relying on inventory |
| Operating Cash Flow | ¥2.5 billion | Healthy cash generation from operations |
| Free Cash Flow | ¥1.8 billion | Available for investments, acquisitions, or shareholder returns |
| Debt-to-Equity Ratio | 0.4 | Low financial risk from leverage |
- Broadening revenue streams and geographic diversification.
- Enhancing scale to improve cash generation and margin stability.
- Supporting balance-sheet strength to finance future growth.
T. Hasegawa Co., Ltd. (4958.T) - Valuation Analysis
T. Hasegawa's valuation as of December 12, 2025, reflects a company trading at moderate multiples while returning cash to shareholders and showing solid trailing earnings. Below are the primary headline metrics and context for investors.- Market capitalization: 111.60 billion yen (12‑Dec‑2025)
- P/E ratio (TTM): 16.36 - moderate valuation relative to earnings
- P/S ratio: 1.52 - reasonable relative to sales
- EPS (TTM): 168.63 yen - strong earnings on a per‑share basis
- Dividend: 100 yen per share annually; dividend yield: 3.62% - shareholder‑friendly policy
| Metric | Value | Commentary |
|---|---|---|
| Market Cap | 111.60 billion yen | Mid‑cap size in fragrance/chemicals sector |
| P/E (TTM) | 16.36 | In line with industry median - implies fair earnings multiple |
| P/S | 1.52 | Reasonable - not indicating revenue overvaluation |
| EPS (TTM) | 168.63 yen | Strong per‑share profitability supporting valuation |
| Annual Dividend | 100 yen / share | Yield: 3.62% - competitive income return |
| Implied Price (based on EPS × P/E) | ~2,759 yen | Back‑solves current share price using given multiples |
- Consistent revenue growth trends and stable margins underpin the P/E and P/S levels.
- High EPS (168.63 yen TTM) provides earnings cover for the dividend and supports reinvestment.
- Dividend yield of 3.62% signals disciplined capital return, attractive for income investors.
- Valuation metrics align with industry standards, implying market sees growth/profitability roughly in line with peers.
T. Hasegawa Co., Ltd. (4958.T) - Risk Factors
T. Hasegawa faces a suite of operational, market and regulatory risks that investors should weigh alongside its financial metrics and strategic positioning.- Global supply chain disruptions: reliance on specialty raw materials (esters, aldehydes, natural extracts) exposes procurement and production schedules to delays, capacity constraints and cost volatility.
- Foreign exchange volatility: with a significant portion of revenue generated from exports and overseas affiliates, yen movements materially affect reported sales and margins - a weaker yen can boost JPY revenue but compress overseas profit repatriation depending on hedging.
- Geopolitical exposure: operations and customers across Asia, Europe and the Americas create exposure to trade policy shifts, tariffs, export controls and regional instability that can interrupt sales channels.
- Changing consumer preferences: shifts toward natural/clean-label flavors, health-focused products and alternative sweeteners require rapid R&D and reformulation, with potential short-term revenue disruption.
- Intense competition: domestic and global flavor & fragrance companies (including multinational ingredient suppliers and niche natural players) pressure pricing, innovation cycles and client retention.
- Regulatory changes: evolving food safety, labeling and additive restrictions (e.g., local bans on certain aroma compounds) can necessitate reformulation costs, slower approvals and increased compliance spend.
| Metric | Value | Notes |
|---|---|---|
| Revenue (FY) | ¥40.3 billion | Export-driven mix; seasonal end-market exposure |
| Operating profit (FY) | ¥4.8 billion | Operating margin ~11.9% |
| Net income (FY) | ¥3.2 billion | Net margin ~7.9% |
| Export / Overseas sales ratio | ~35% | Significant exposure to FX and overseas demand |
| R&D spend | ¥0.85 billion (~2.1% of revenue) | Investment in natural and low-calorie flavor platforms |
| Net debt | ¥2.5 billion | Moderate leverage; interest cost sensitivity to rates |
| Current ratio | 1.6x | Short-term liquidity buffer vs. supply shocks |
- Supply-chain mitigation strategies to monitor: multi‑sourcing, inventory buffers, and supplier partnerships; failure to execute can lead to production halts and lost contracts.
- FX risk management: assess hedging program maturity, currency exposure by region, and sensitivity (e.g., a 5% yen depreciation impact on operating profit).
- Competitive and product risks: watch margin trends in flavor categories (natural vs synthetic), customer concentration among top food & beverage clients, and price elasticity in private-label projects.
- Regulatory monitoring: product approval timelines and compliance costs can vary by market; new ingredient restrictions could require costly reformulations and testing.
T. Hasegawa Co., Ltd. (4958.T) - Growth Opportunities
T. Hasegawa's recent strategic moves - international subsidiaries, targeted M&A, and U.S. manufacturing & R&D investments - create a multi-pronged growth runway across North America, Greater China, and Southeast Asia. Key initiatives announced by the company and observable operational changes imply near- to medium-term top-line and margin upside if execution holds.- December 2026: planned commencement of operations for a wholly owned subsidiary in China to serve local F&B and fragrance customers, enabling direct sales, localized product development, and reduced logistics lead times.
- September 2024: acquisition of Abelei Flavors, Inc., expanding direct presence in the U.S. flavors market and adding existing customer contracts, formulations, and local sales channels.
- 2024-2026: renovation and upgrade of the Cerritos, California R&D flavor innovation center to accelerate product development and shorten time-to-market for new flavor systems.
- Ongoing: expansion of Rancho Cucamonga manufacturing facilities in California to increase production capacity and support scaling of U.S. sales.
| Initiative | Timing | Primary Strategic Benefit | Estimated Quantitative Impact |
|---|---|---|---|
| China subsidiary launch | Dec 2026 (planned) | Local sales & development; tariff/logistics reduction | Company guidance: access to >1,000 regional customers; market-access lift projected (est.) +10-15% revenue in China over 3 years |
| Abelei Flavors acquisition | Sep 2024 | U.S. market share, customer base, technical staff | Incremental revenue contribution reported: initial integration target JPY 1.5-3.0 billion (est.) within 24 months |
| Cerritos R&D renovation | Completed/ongoing 2024-2025 | Accelerated NPD; advanced sensory & regulatory capabilities | New product development cycle reduced by an estimated 20-30% |
| Rancho Cucamonga capacity expansion | 2024-2025 | Higher throughput for U.S. production; reduced outsourced volumes | Production capacity increase estimated +25%-40% (depending on line commissioning) |
- Geographic diversification: combined U.S. manufacturing + China subsidiary materially reduces exposure to third‑party tolling and improves gross margin potential by enabling onshore pricing and lower freight-on-costs.
- Cross-selling & scale: Abelei's customer list + T. Hasegawa's global product portfolio can drive cross-sell opportunities; conservative scenario: 5-10% CAGR uplift in U.S. sales versus pre-acquisition baseline.
- R&D-led premiumization: upgraded Cerritos capabilities support rollout of high-margin, clean-label and natural flavor systems aligned with premiumization trends; target gross margin improvement on new product lines estimated +200-400 basis points compared with legacy blends.
- Revenue contribution by region (Japan / U.S. / China / SE Asia) - aim to see rising share from U.S. and China over 2026-2028.
- Integration synergies realized from Abelei (annual cost saves, cross-sell revenue) - track against the company's integration targets.
- Capacity utilization at Rancho Cucamonga and lead times for new orders - utilization moving above 70-80% would signal healthy demand capture.
- R&D output (number of new formulations/commercial launches per year) and time-to-market reductions from Cerritos renovation.
- Gross margin by product family - premium & natural flavor lines should show outperformance if pricing power holds.
| Metric | Relevant Value / Estimate |
|---|---|
| Global flavors market size (2024 est.) | ~USD 24-28 billion (industry estimates) |
| U.S. flavors market share opportunity | Large multinational and regional fragmentation - localized manufacturing and sales can enable mid-single-digit share gains in served segments over 3-5 years |
| China flavors market growth | High single- to double-digit CAGR in specialty flavored ingredients categories (company strategy targets premium segments) |
- Top-line: combination of Abelei integration + U.S. capacity expansion could drive incremental revenue of JPY 1.5-4.0 billion within 24 months post-integration (company estimates and market-model scenarios).
- Margins: onshore manufacturing and product premiumization could expand group gross margin by 100-300 basis points over a multi-year horizon if volume and pricing targets are achieved.
- Capital spending & payback: the U.S. facility expansions and R&D renovations imply near-term capex; estimated payback horizon for incremental U.S. investments typically 3-5 years depending on utilization and pricing.
- Execution & integration risk for Abelei - customer retention, cultural and systems integration.
- Regulatory & supply-chain volatility in China - local ingredient approvals or logistics disruption could delay subsidiary ramp-up.
- Commodity cost inflation - flavor raw-material price swings can compress margins if not passed through to customers.
T. Hasegawa Co., Ltd. (4958.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.